Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.185
-0.012 (-5.91%)
At close: Nov 4, 2024, 4:00 PM
0.187
+0.002 (0.97%)
Pre-market: Nov 5, 2024, 6:48 AM EST
Applied DNA Sciences Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Net Income | -7.29 | -9.95 | -8.27 | -14.29 | -13.03 | -8.62 | |
| Depreciation & Amortization | 0.95 | 1.36 | 1.29 | 0.84 | 0.29 | 0.39 | |
| Other Amortization | - | - | - | - | 0.03 | 0.02 | |
| Loss (Gain) From Sale of Assets | - | -0.01 | - | 0.21 | - | - | |
| Asset Writedown & Restructuring Costs | - | 0.06 | - | 0.82 | - | 0.25 | |
| Stock-Based Compensation | 0.88 | 1.03 | 2.52 | 1.67 | 1 | 1.13 | |
| Provision & Write-off of Bad Debts | 0.02 | -0.24 | 0.27 | 0.03 | 0.05 | 0.01 | |
| Other Operating Activities | -7.52 | -0.93 | -5.74 | 0.94 | -0 | -0.72 | |
| Change in Accounts Receivable | 0.15 | 3.05 | -0.53 | -2.64 | 0.6 | 0.64 | |
| Change in Inventory | -0.19 | 0.27 | 0.77 | -0.87 | -0.35 | 0.08 | |
| Change in Accounts Payable | -0.22 | -1.35 | 0.93 | 0.09 | 0.43 | 0.67 | |
| Change in Unearned Revenue | -0.03 | -0.29 | 0.28 | -0.23 | -0.12 | -0.73 | |
| Change in Other Net Operating Assets | 0.11 | 0.77 | -0.49 | 0.03 | -0.03 | 0.02 | |
| Operating Cash Flow | -13.14 | -6.22 | -8.98 | -13.39 | -11.14 | -6.86 | |
| Capital Expenditures | -0.96 | -1.14 | -0.49 | -2.55 | -1.06 | -0.07 | |
| Sale of Property, Plant & Equipment | - | 0.05 | - | - | - | - | |
| Investing Cash Flow | -0.96 | -1.1 | -0.49 | -2.55 | -1.06 | -0.07 | |
| Long-Term Debt Issued | - | - | - | - | 0.85 | 1.99 | |
| Total Debt Issued | - | - | - | - | 0.85 | 1.99 | |
| Long-Term Debt Repaid | - | - | - | -1.67 | -0.11 | - | |
| Net Debt Issued (Repaid) | - | - | - | -1.67 | 0.74 | 1.99 | |
| Issuance of Common Stock | 13.79 | - | 18.13 | 16.37 | 18.7 | 3.85 | |
| Other Financing Activities | - | - | - | - | - | -0.01 | |
| Financing Cash Flow | 13.79 | - | 18.13 | 14.7 | 19.43 | 5.83 | |
| Net Cash Flow | -0.31 | -7.31 | 8.66 | -1.23 | 7.23 | -1.1 | |
| Free Cash Flow | -14.1 | -7.36 | -9.47 | -15.94 | -12.21 | -6.93 | |
| Free Cash Flow Margin | -415.04% | -55.05% | -52.10% | -176.53% | -631.98% | -128.58% | |
| Free Cash Flow Per Share | -9.14 | -11.26 | -21.11 | -46.08 | -62.29 | -150.34 | |
| Cash Interest Paid | - | - | - | - | 0.05 | - | |
| Levered Free Cash Flow | -8.28 | -3.68 | -4.48 | -10.48 | -7.17 | -4.15 | |
| Unlevered Free Cash Flow | -8.28 | -3.68 | -4.48 | -10.48 | -7.12 | -4.07 | |
| Change in Net Working Capital | -0.17 | -1.91 | -0.93 | 2.62 | -0.49 | -0.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.